Table 2.
Sources | Immunomodulating Agents | Component Mechanism | Pig-to-NHP Xenotransplantation | Reference |
---|---|---|---|---|
Under investigation | Anti-CD154 Ab | Blockade of CD40−CD154 | Kidney, heart, islets | [145,146,147] |
Cobra venom factor | Inhibition of complement system | Islets | [34] | |
Anti-CD40 Ab | Blockade of CD40−CD154 costimulatory signal | Kidney, heart, islets | [145,147,148] | |
FDA non-approved, commercially available | Eculizumab | Blockade of the C5b-9 MAC | Pancreas | [149] |
Etanercept | Anti-TNF-alpha inhibitor | Islets | [150] | |
Intravenous immunoglobulin | Modulating antigen presenting cell activity and complement activation | Hearts | [151,152] | |
IL-1 receptor antagonist | IL-1 inhibitor | Heart | [153] | |
IL-6 receptor antagonist | IL-6 inhibitor | Islet, Kidney, Heart | [154,155] | |
FDA approved for transplantation | Tacrolimus | Inhibition of the enzyme calcineurin by binding of FKBP-12 | Pancreas | [156,157] |
Mycophenolic acids | Inhibition of the lymphocyte cycle by blocking inosine monophosphate dehydrogenase | Kidney, heart, islets | [158,159] |
Abbreviation: Ab, antibody; NHP, non-human primate; MAC, membrane attack complex; TNF, tumor necrosis factor; IL, interleukin; FDA, the Food and Drug Administration.